Document › Details
IMD Natural Solutions GmbH. (8/31/15). "Press Release: IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies". Dortmund & Taizhou City.
IMD Natural Solutions GmbH (INS), a natural product company, today announced a collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun; SHA:600267) under which INS receives a EUR4 million equity investment and provides Hisun access to INS' unique natural product lead discovery platform for antimicrobials and antioxidants for the food, beverage and personal care industries. Furthermore, INS will benefit from Hisun's production know-how and capabilities.
The investment paves the way for INS to further develop and commercialize its innovative antimicrobial preservation product for use in food, beverage and personal care applications. It is a new, fermentation-based all-natural agent with superior efficacy against yeasts, molds and other microbial strains and has shown bioactivity against microbial organisms that have adapted to current preservative agents. The collaboration provides Hisun access to INS' natural product databases and technology for the identification and development of suitable active natural ingredients for various life science applications.
"The investment by Hisun into INS and our access to Hisun's production know-how and capabilities are an important step in driving our core product towards market entry," said Dr. Thomas Henkel, Managing Director of INS.
"The combination of INS's natural product platform and product candidates with Hisun's production know-how creates a unique platform for the development and commercialization of new, innovative products and thus strengthens our market position and pipeline potential substantially," said Mr. Bai Hua, President and CEO of Hisun.
About IMD Natural Solutions GmbH
IMD Natural Solutions GmbH (INS) was founded in 2012 in Dortmund, Germany. The management has more than 20 years of experience in the discovery and development of active compounds derived from natural products. INS owns extensive proprietary natural product and genetic source collections, a unique technology platform as well as broad chemical and biological databases. INS develops and commercializes innovative ingredients - with a special focus on preservative agents - derived from totally natural sources. The main target markets are in the food, beverages and personal care industries.
About Zhejiang Hisun Pharmaceuticals
Founded in 1956, the vision of Zhejiang Hisun Pharmaceuticals Co., Ltd. (stock code 600267) is to become "a widely respected international pharmaceutical company" by advancing its mission of "persisting in pharmaceutical innovation for the benefit of human beings." The Company focuses on the integration of pharmaceutical research and development (R&D) with production resources in order to provide its global customers with outstanding products and services. To date, over 40 of the Company's products have passed certification by the FDA (U.S.), EDQM (EU), TGA (Australia), KFDA (Korea), etc., and are sold in more than 30 countries worldwide. To learn more about Hisun, please visit
Dr. Thomas Henkel, Managing Director
IMD Natural Solutions GmbH
Wei Zhang, Secretary of board
Zhejiang HISUN Pharmaceutical Co., Ltd.
Raimund Gabriel, Managing Partner
MC Services AG
Record changed: 2016-04-30
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)